Executive Management

Erik Gatenholm
CEO

Born 1989. CEO since 2016.

Education and work experience:
B.Sc. at Virginia Tech University and an MBA from Gothenburg University. Erik has documented success in biotechnology entrepreneurship with more than 13 years of entrepreneurial experience. Honors include: Forbes 30 Under 30, MIT Review 35 Under 35, and Entrepreneur of the year 2020.

Other board assignments:
Board member of CELLINK AB and chairman of CELLINK Options AB.

Shareholding in CELLINK:
A-stock: 848,958, B-stock: 8,948,036 Ownership: 19.0%, Voting right: 26.8%

Hector Martinez
CTO

Born 1985. CTO since 2016.

Education and work experience:
As mechanical and biomedical engineer, Héctor received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has eight years’ experience in biomaterials, tissue engineering and 3D bioprinting technologies.

Other board assignments:
Board member of CELLINK Options AB.

Shareholding in CELLINK:
A-stock: 567,709, B-stock: 5,867,284 Ownership: 12.5%, Voting right: 17.7%

Gusten Danielsson
CFO

Born 1992. CFO since 2016.

Education and work experience:
M.Sc. in Innovation & Industrial Management from Gothenburg University. Founder of Escape House and Matvänner. Previously CEO of Handels Capital Management.

Other board assignments:
Board member of Escape House AB, Matvänner AB, Castlemaine Consulting AB and CELLINK Options AB.

Shareholding in CELLINK:
A-stock: 83,333, B-stock: 1,289,232 Ownership: 2.7%, Voting right: 3.3% Options: 176,000

Artur Aira
Business Area Manager

Born 1967. Business Area Manager Bioprinting since 2020.

Education and work experience:
Medtech Eng., and MBA, Chalmers. More than 25 years’ experience in Life Science (biotech, Pharma, Diagnostics). Former CEO of Organon, bioMerieux Nordics, Ad-dtech Life Lifescience, Addlife dvlp, COO and Exec VP Addlife and Abigo Medical AB.

Other board assignments:
Has Board member experience of more than 35 companies. Board member of Integrum and Predicare. Board member of CELLINK 2017-2020.

Shareholding in CELLINK:
Options: 120,000

Dr. Holger Eickhoff
Business Area Manager

Born 1965. Business Area Manager Industrial Solutions since 2020. CEO SCIENION since 2001.

Education and work experience:
Diploma in Chemistry Heidelberg University. PhD in Biology University Jena. Post Doc at Max Planck for Molecular Genetics. Founder SCIENION.

Other board assignments: –

Shareholding in CELLINK:
B-stock: 251,660 Ownership: 0.5%, Voting right: 0.4%

Dr. Jonas Schöndube,
Business Area Manager

Born 1985. Business Area Manager Biosciences since 2020.

Education and work experience:
M.Sc. in Micro and Nanosystems from ETH Zurich. PhD in Engineering from University of Freiburg. Founder and CEO (2014 – May 2021) of CYTENA.

Other board assignments:
Board member CYTENA Bioprocess Solutions co. Ltd., Taiwan.

Shareholding in CELLINK:
B-stock: 238,168, Options: 60,000 Ownership: 0.4%, Voting right: 0.4%

Shareholding in CELLINK per December 31, 2020.